I am not a short, just a realist. Companies that have to do a RS usually do. Sure they could hit a home run courtesy of the FDA and I hope they do but it's only "hope". CHTP longs like me are pi$$ed enough with their forward leaning statements about the trials last year. Oh yes a RS is probably coming especially after a secondary that will have to be done prior to the 6 months they have to get the stock up.